Table 3.
Adjusted odds ratios (95% CIs) for MetS and its components according to SF quartile by gender (odds ratios [95% confidence intervals])
| Q1 | Q2 | Q3 | Q4 | p trend | |
|---|---|---|---|---|---|
| Men (n 561) | |||||
| Abdominal obesity | |||||
| Crudea | 1.00 | 0.84 (0.52, 1.35) | 0.79 (0.48, 1.28) | 1.07 (0.67, 1.71) | .561 |
| Model1b | 1.00 | 0.93 (0.57, 1.54) | 0.81 (0.48, 1.35) | 1.19 (0.72, 1.97) | .384 |
| Model1 + BMI | 1.00 | 0.77 (0.38, 1.52) | 0.46 (0.23, 0.92) | 0.52 (0.26, 1.04) | .079 |
| Hypertension | |||||
| Crudea | 1.00 | 0.73 (0.45, 1.19) | 0.77 (0.47, 1.25) | 0.92 (0.57, 1.50) | .906 |
| Model1b | 1.00 | 0.74 (0.42, 1.30) | 0.65 (0.37, 1.14) | 0.87 (0.49, 1.55) | .423 |
| Model1 + BMI | 1.00 | 0.77 (0.44, 1.35) | 0.68 (0.38, 1.20) | 0.88 (0.50, 1.58) | .943 |
| Hypertriglyceridemia | |||||
| Crudea | 1.00 | 1.43 (0.83, 2.48) | 2.00 (1.17, 3.41) | 3.68 (2.19, 6.20) | <.001 |
| Model1b | 1.00 | 1.54 (0.88, 2.70) | 2.15 (1.24, 3.74) | 4.14 (2.39, 7.19) | <.001 |
| Model1 + BMI | 1.00 | 1.48 (0.82, 2.68) | 1.99 (1.12, 3.55) | 3.63 (2.04, 6.45) | <.001 |
| Low HDL‐C | |||||
| Crudea | 1.00 | 0.62 (0.35, 1.10) | 0.79 (0.46, 1.38) | 1.31 (0.78, 2.18) | .069 |
| Model1b | 1.00 | 0.63 (0.35, 1.14) | 0.85 (0.48, 1.51) | 1.42 (0.82, 2.46) | .040 |
| Model1 + BMI | 1.00 | 0.58 (0.31, 1.05) | 0.75 (0.42, 1.36) | 1.19 (0.68, 2.09) | .155 |
| Elevated fasting glucose | |||||
| Crudea | 1.00 | 1.22 (0.74, 1.97) | 1.50 (0.92, 2.44) | 1.58 (0.98, 2.55) | .067 |
| Model1b | 1.00 | 1.57 (0.92, 2.66) | 1.77 (1.04, 3.03) | 2.30 (1.34, 3.95) | .005 |
| Model1 + BMI | 1.00 | 1.55 (0.91, 2.64) | 1.72 (1.01, 2.95) | 2.13 (1.23, 3.68) | .013 |
| MetS | |||||
| Crudea | 1.00 | 0.91 (0.55, 1.51) | 1.04 (0.63, 1.72) | 1.79 (1.10, 2.91) | .004 |
| Model1b | 1.00 | 1.10 (0.65, 1.87) | 1.17 (0.69, 1.98) | 2.23 (1.32, 3.77) | .001 |
| Model1 + BMI | 1.00 | 0.84 (0.42, 1.67) | 0.66 (0.33, 1.34) | 1.05 (0.53, 2.07) | .652 |
| Women (n1098) | |||||
| Abdominal obesity | |||||
| Crudea | 1.00 | 1.19 (0.83, 1.69) | 2.80 (1.97, 3.98) | 4.94 (3.44, 7.10) | ＜.001 |
| Model1b | 1.00 | 0.83 (0.56, 1.24) | 1.01 (0.67, 1.54) | 1.02 (0.65, 1.62) | .669 |
| Model1 + BMI | 1.00 | 0.85 (0.48, 1.49) | 1.33 (0.75, 2.35) | 1.21 (0.65, 2.25) | .468 |
| Hypertension | |||||
| Crudea | 1.00 | 0.97 (0.65, 1.43) | 2.67 (1.85, 3.84) | 6.43 (4.43, 9.35) | <.001 |
| Model1b | 1.00 | 0.51 (0.31, 0.83) | 0.63 (0.39, 1.03) | 0.80 (0.48, 1.34) | .676 |
| Model1 + BMI | 1.00 | 0.49 (0.29, 0.81) | 0.61 (0.37, 1.00) | 0.75 (0.44, 1.27) | .679 |
| Hypertriglyceridemia | |||||
| Crudea | 1.00 | 1.06 (0.66, 1.69) | 2.75 (1.80, 4.21) | 5.04 (3.33, 7.62) | <.001 |
| Model1b | 1.00 | 0.74 (0.44, 1.23) | 1.11 (0.68, 1.81) | 1.43 (0.86, 2.38) | .019 |
| Model1 + BMI | 1.00 | 0.69 (0.41, 1.18) | 1.12 (0.67, 1.85) | 1.40 (0.83, 2.36) | .023 |
| Low HDL‐C | |||||
| Crudea | 1.00 | 1.02 (0.70, 1.48) | 0.96 (0.66, 1.40) | 1.32 (0.92, 1.90) | .085 |
| Model1b | 1.00 | 0.91 (0.62, 1.34) | 0.68 (0.44, 1.03) | 0.82 (0.52, 1.29) | .639 |
| Model1 + BMI | 1.00 | 0.90 (0.61, 1.34) | 0.68 (0.44, 1.05) | 0.82 (0.52, 1.30) | .642 |
| Elevated fasting glucose | |||||
| Crudea | 1.00 | 1.09 (0.68, 1.74) | 2.89 (1.89, 4.42) | 5.42 (3.58, 8.19) | <.001 |
| Model1b | 1.00 | 0.79 (0.48, 1.31) | 1.24 (0.76, 2.01) | 1.64 (0.99, 2.72) | .005 |
| Model1 + BMI | 1.00 | 0.77 (0.46, 1.29) | 1.25 (0.76, 2.04) | 1.62 (0.97, 2.69) | .006 |
| MetS | |||||
| Crudea | 1.00 | 1.10 (0.71, 1.71) | 2.67 (1.78, 3.99) | 6.04 (4.06, 8.97) | <.001 |
| Model1b | 1.00 | 0.65 (0.39, 1.08) | 0.76 (0.47, 1.25) | 1.09 (0.65, 1.80) | .088 |
| Model1 + BMI | 1.00 | 0.49 (0.27, 0.91) | 0.68 (0.38, 1.20) | 0.91 (0.51, 1.64) | .214 |
Abbreviations: BMI, body mass index; MetS, metabolic syndrome.
a
Crude: unadjusted.
b
Model 1: adjusted for age, city level, smoking, drinking, weekly moderate‐to‐vigorous activity, dietary factors (total energy intake, fat intake, and protein intake), and hs‐CRP.